UC Asset Praises New Cannabis Policies from Trump's Administration

UC Asset Celebrates Pro-Cannabis Policy Development by Trump's Office

On August 11, 2025, UC Asset Limited Partnership (OTCQB: UCASU) shared an enthusiastic response to the recent policy developments from President Trump's office regarding cannabis reform. According to a report from The Wall Street Journal titled "Trump Weighs Reclassifying Marijuana as Less Dangerous Drug," there are discussions to potentially downgrade the classification of marijuana from a Schedule I to a Schedule III substance. This major policy shift could not only ease the legal restrictions surrounding cannabis but also create opportunities for tax benefits and further medical research in the field.

Strategic Investments in the Cannabis Sector

Larry Wu, the founder and managing partner of UC Asset, stated, "Since the beginning of this year, we have been preparing for a significant policy breakthrough in the cannabis market and have executed an investment strategy in anticipation of this." Earlier this year, UC Asset made substantial strides in expanding its cannabis property portfolio, doubling its holdings from $1.6 million to $3.1 million. Additionally, the firm is actively pursuing a $5 million secondary public offering (SPO) to further invest in cannabis properties.

The company has already filed with the SEC for this SPO, which has undergone two rounds of review. Wu remains optimistic about securing the necessary approvals in the months to come.

Impressive Returns on Investment

The performance of UC Asset's cannabis portfolio has been impressive. In their amended Form 1-A, they reported a 14.4% return on investment (ROI), which is notable compared to the industry average. Wu elaborated, "For context, other public companies engaged in similar markets have reported ROI figures ranging from 11% to 12%. Our figures stand out in stark contrast to that."

Despite the strong performance, Wu emphasizes that investors should conduct their own due diligence as figures from peer filings may not capture the complete picture. The anticipated policy changes could further enhance UC Asset's position in the marketplace.

Second Wave of Growth Expected

In light of these developments, UC Asset is predicting a significant resurgence in the cannabis industry. Wu points out that while the sector has seen consistent growth, it also experienced a dramatic decline—losing 95% of its investment equity value according to the cannabis ETF index MSOS. "Emerging industries typically do not reach maturity after just one growth wave, and we are closely monitoring signals that indicate the start of a second wave in the cannabis market. Major policy changes could serve as the catalyst for this expansion," he explained.

Potential Partnerships

UC Asset is poised to collaborate with investors looking to capitalize on the anticipated market rebound. "We believe we are among a select group of portfolio managers who are ready for strategic expansion and keen to partner with investors at this juncture. As a public company, we stand out for currently pursuing a secondary public offering in the cannabis property niche," said Wu.

Historical market performance indicates that cannabis property investments could yield substantial returns, particularly during periods of rapid market growth. Wu cites that between 2018 and 2021, market-leading cannabis companies saw their stock prices soar, whereas cannabis property firms also experienced astonishing growth in valuations.

Seize the Moment

Wu concludes with a strong message about seizing the opportunities presented by the evolving regulatory landscape. "The potential for growth in our sector is tremendously exciting. It’s imperative for us to act decisively as these opportunities arise."

To learn more about UC Asset LP and its innovative strategies in real estate investing, visit their website at www.ucasset.com.

Disclaimer

This article includes forward-looking statements under the Private Securities Litigation Reform Act of 1995. Risks and uncertainties abound; thus, it’s advisable not to place undue reliance on these statements as outcomes may vary significantly based on various factors.